The observation that pharmacological inhibition of the kinase domain of PFKFB4 suppresses cell proliferation thus provides “proof-of-concept” that PFKFB4 kinase, as opposed to bisphosphatase inhibitors, may have utility as anti-cancer agents. This evidence concerns the gene PFKFB4 and cancer.